Assignee
EXELIXIS INC
US123 patents
Top patents by PatentIndex Score
US7579473B2Aug 25, 2009
c-Met modulators and methods of use
EXELIXIS INC95 citations98
US10039757B2Aug 7, 2018
C-Met modulator pharmaceutical compositions
EXELIXIS INC33 citations97
US10034873B2Jul 31, 2018
C-met modulator pharmaceutical compositions
EXELIXIS INC33 citations97
US7989622B2Aug 2, 2011
Phosphatidylinositol 3-kinase inhibitors and methods of their use
EXELIXIS INC64 citations97
US7265131B2Sep 4, 2007
Isoquinolinone derivatives and their use as therapeutic agents
EXELIXIS INC145 citations97
US9809549B2Nov 7, 2017
Malate salt of N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer
EXELIXIS INC30 citations96
US7704995B2Apr 27, 2010
Protein kinase modulators and methods of use
EXELIXIS INC64 citations96
US6515109B1Feb 4, 2003
Human ECT2 polypeptide
EXELIXIS INC179 citations96
US7803839B2Sep 28, 2010
Azetidines as MEK inhibitors for the treatment of proliferative diseases
EXELIXIS INC46 citations95
US11098015B2Aug 24, 2021
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
EXELIXIS INC9 citations93
US9861624B2Jan 9, 2018
Method of treating cancer
EXELIXIS INC24 citations93
US7999006B2Aug 16, 2011
Methods of using MEK inhibitors
EXELIXIS INC51 citations93
US7977345B2Jul 12, 2011
c-MET modulators and method of use
EXELIXIS INC48 citations93
US6511824B1Jan 28, 2003
Nucleic acids and polypeptides of invertebrate TWIK channels and methods of use
EXELIXIS INC195 citations93
US6489127B1Dec 3, 2002
Methods for identifying anti-cancer drug targets
EXELIXIS INC194 citations93
US6703491B1Mar 9, 2004
Drosophila sequences
EXELIXIS INC123 citations92
US10501418B2Dec 10, 2019
Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
EXELIXIS INC12 citations91
US10166225B2Jan 1, 2019
Method for treating osteoporosis
EXELIXIS INC23 citations91
US9969692B2May 15, 2018
Process for preparing quinoline derivatives
EXELIXIS INC21 citations91
US9365516B2Jun 14, 2016
Process for preparing quinoline derivatives
EXELIXIS INC27 citations91
US8372851B2Feb 12, 2013
Pyrazolo pyrimidines as casein kinase II (CK2) modulators
EXELIXIS INC20 citations91
US7915250B2Mar 29, 2011
Azetidines as MEK inhibitors for the treatment of proliferative diseases
EXELIXIS INC22 citations91
US7595311B2Sep 29, 2009
Azepinoindole derivatives as pharmaceutical agents
EXELIXIS INC29 citations91
US7485634B2Feb 3, 2009
Azepinoindole and pyridoindole derivatives as pharmaceutical agents
EXELIXIS INC49 citations91
US6852290B2Feb 8, 2005
Multi-well apparatus
EXELIXIS INC36 citations90
US6688255B2Feb 10, 2004
Robotic apparatus and methods for maintaining stocks of small organisms
EXELIXIS INC23 citations90
US7413910B2Aug 19, 2008
Multi-well apparatus
EXELIXIS INC19 citations88
US11731941B2Aug 22, 2023
Crystalline solid forms of salts of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
EXELIXIS INC8 citations86
US11279675B2Mar 22, 2022
Crystalline solid forms of salts of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1, 1-dicarboxamide, processes for making, and methods of use
EXELIXIS INC10 citations86
US11724986B2Aug 15, 2023
Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
EXELIXIS INC6 citations84
US10273211B2Apr 30, 2019
Metabolites of N-{4-([6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
EXELIXIS INC17 citations84
US10159666B2Dec 25, 2018
Dosing of cabozantinib formulations
EXELIXIS INC21 citations84
US11298349B2Apr 12, 2022
Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
EXELIXIS INC4 citations83
US11124482B2Sep 21, 2021
C-met modulators and methods of use
EXELIXIS INC6 citations83
US11091439B2Aug 17, 2021
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer
EXELIXIS INC8 citations83
US11091440B2Aug 17, 2021
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)- N′-(4-fluorophenyl)cyclopropane-1,1 -dicarboxamide, and crystalline forms thereof for the treatment of cancer
EXELIXIS INC8 citations83
US10548888B2Feb 4, 2020
C-Met modulator pharmaceutical compositions
EXELIXIS INC9 citations83
US10543206B2Jan 28, 2020
Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
EXELIXIS INC9 citations83
US10123999B2Nov 13, 2018
Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
EXELIXIS INC9 citations83
US8362002B2Jan 29, 2013
Azetidines as MEK inhibitors for the treatment of proliferative diseases
EXELIXIS INC12 citations83
US11433064B2Sep 6, 2022
Methods of using c-Met modulators
EXELIXIS INC6 citations82
US10851061B2Dec 1, 2020
Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
EXELIXIS INC8 citations82
US10736886B2Aug 11, 2020
Methods of using c-Met modulators
EXELIXIS INC11 citations82
US7816353B2Oct 19, 2010
P70S6 kinase modulators and method of use
EXELIXIS INC8 citations82
US8044062B2Oct 25, 2011
Substituted pyrido[2,3-d]pyrimidin-7(8H)-one inhibitors of phospatidylinositol 3-kinase alpha
EXELIXIS INC15 citations81
US11141413B2Oct 12, 2021
Method of treating renal cell carcinoma using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioate
EXELIXIS INC8 citations77
US11124481B2Sep 21, 2021
Method of preparing fluorine-18 labeled Cabozantinib and its analogs
EXELIXIS INC7 citations75
US11708367B2Jul 25, 2023
Compounds for the treatment of kinase-dependent disorders
EXELIXIS INC2 citations72
US11542259B2Jan 3, 2023
Compounds for the treatment of kinase-dependent disorders
EXELIXIS INC3 citations72
US11123338B2Sep 21, 2021
C-met modulator pharmaceutical compositions
EXELIXIS INC2 citations72
Showing the top 50 of 123 patents by PatentIndex Score.